Respiratory pharmacology: set up and use of novel in vitro assays
Listed on 2026-01-02
-
Research/Development
Research Scientist, Clinical Research -
Healthcare
Clinical Research
Organisation/Company Dipartimento di Scienze del Farmaco Research Field Pharmacological sciences » Other Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Country Italy Final date to receive applications 7 Jan 2026 - 23:59 (UTC) Type of Contract To be defined Job Status Not Applicable Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure?
No
The research program to be carried out in collaboration with Chiesi Farmaceutici will focus on testing different inhibitory compounds targeting the epithelial–mesenchymal transition using both endpoint and label-free approaches. In addition, changes in the expression of mucin genes (e.g. MUC5AC and MUC5B) will be evaluated in respiratory epithelial cells (e.g. BEAS-2B cell line). Finally, the collaboration aims to establish in vitro assays to assess respiratory epithelial remodeling using 3D approaches and to characterize compounds capable of modulating the remodeling induced by TGF-β1 and fibrotic cocktails.
master's degree or single-cycle master's degree in Pharmacy or Pharmaceutical Chemistry and Technology – LM-13
- Italy
Eligibility of fellows: country/ies of residence:
- EUROPE
Eligibility of fellows: nationality/ies:
#J-18808-Ljbffr(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).